Novo Nordisk ends Ozempic kidney trial early after seeing beneficial results
Novo Nordisk will stop its kidney trial early after the diabetic drug Ozempic showed promising results.
Source: wxyz.com
Stay updated with breaking news from Kidney Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Novo Nordisk will stop its kidney trial early after the diabetic drug Ozempic showed promising results.
MARKET WRAPS Stocks: European stocks struggled for direction on Wednesday as investors turned cautious ahead of the Federal Reserve minutes due after the close, and U.S. inflation data due... -October 11, 2023 at 05:46 am EDT - MarketScreener
MARKET WRAPS Watch For: PPI for September; FOMC Meeting Minutes; Canada Building Permits for August Today's Top Headlines/Must Reads: - Profits Are Making a Comeback - Muni... -October 11, 2023 at 06:16 am EDT - MarketScreener